Rheumatoid Arthritis Trial, Recruiting NCT06771427 Sponsor: Taipei Veterans General Hospital, Taiwan Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT06771427
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Dry Eye Syndrome:

  • People aged between 20 and 75 years
  • People whose Schirmer's test result (a test that measures tear production) shows less than 10 mm in 5 minutes, indicating low tear production

For people with Sjögren's Syndrome (an immune system condition affecting moisture-producing glands):

  • People aged between 20 and 75 years
  • People with either primary or secondary Sjögren's Syndrome
  • People whose condition meets the 2002 American-European Consensus Criteria for Sjögren's Syndrome (confirm with trial site)
  • People with no abnormal results in immune system, liver, kidney, or blood function tests

For Healthy Control participants (people without these conditions):

  • People aged between 20 and 75 years
  • People without any ongoing chronic (long-term) illness

Who may not be able to join:

For people with Dry Eye Syndrome:

  • People who are pregnant
  • People who currently have eye inflammation or an infectious eye disease
  • People who have had eye surgery

For people with Sjögren's Syndrome:

  • People with a history of alcohol misuse, diabetes, or a serious life-threatening health condition
  • People who are pregnant or breastfeeding
  • People who have received high-dose steroid treatment (steroid pulse therapy) within the three months before the study begins

For Healthy Control participants:

  • People who have Sjögren's Syndrome or Dry Eye Syndrome

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ching-Mao Chang, M.D., Ph.D., Taipei Veterans General Hospital, Taiwan

Phone: 8862285757453

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Taipei Veterans General Hospital, Taiwan
Registry
ClinicalTrials.gov
Start date
16 January 2025
Est. completion
30 April 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Schirmer's test; Ocular Surface Disease Index (OSDI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov